Synopsis: Anupam Rasayan India Limited has highlighted significant growth opportunities arising from its proposed acquisition of Bliss GVS Pharma. The company expects revenue growth to recover to the 25–30 percent range in FY27 and has guided for EBITDA margins of...
Synopsis: Anupam Rasayan India Limited, a leading specialty chemicals company, announced on May 23, 2026, that it has signed a definitive agreement to acquire a 43.3% – 48.2% equity stake in Bliss GVS Pharma Limited, along with an open offer to public...
SYNOPSIS: This chemical major completes a $150 million acquisition of US-based Jayhawk Fine Chemicals, funded through equity and debt. The company expects full consolidation and EPS accretion, strengthening its global specialty chemicals platform. During Monday’s...
Anupam Rasayan IPO Review 2021: Anupam Rasayan IPO opens on March 12 to March 16, 2021. In this article, we cover the Anupam Rasayan IPO Review and look into important IPO information and find out the possible prospects of the company. Let’s get started. Anupam...
